FGF2 and FGFR1 signaling regulate functional recovery following cuprizone demyelination

Neuroscience Letters

Volumn 548, Issue , 2013, Pages 280-285

  Mierzwa, Amanda J ^a   Zhou, Yong Xing ^a,b   Hibbits, Norah ^a   Vana, Adam C ^a   Armstrong, Regina C ^a  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^b FLORIDA STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Corpus callosum; Growth factor; Multiple sclerosis; Remyelination; Sociability; Wheel activity

Indexed keywords

CUPRIZONE; TAMOXIFEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORPUS CALLOSUM; DEMYELINATION; FIBROBLAST GROWTH FACTOR 2 GENE; FIBROBLAST GROWTH FACTOR RECEPTOR 2 GENE; GENE; GENE DELETION; GENE SILENCING; GENOTYPE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RUNNING;

CORPUS CALLOSUM; CUP; CUPRIZONE; FGF2; FGFR1; FIBROBLAST GROWTH FACTOR 2 LIGAND; FIBROBLAST GROWTH FACTOR RECEPTOR 1; FL; FLOXED GENE; GENE ENCODING MURINE FIBROBLAST GROWTH FACTOR 2; GENE ENCODING MURINE FIBROBLAST GROWTH FACTOR RECEPTOR 1; GROWTH FACTOR; MOG; MS; MULTIPLE SCLEROSIS; MYELIN OLIGODENDROCYTE PROTEIN; OLCS; OLIGODENDROCYTE LINEAGE CELLS; PLP/CREERT; REMYELINATION; SOCIABILITY; TAM; TAMOXIFEN; TRANSGENE ENCODING THE MURINE PROTEOLIPID PROTEIN PROMOTER DRIVING CRE RECOMBINASE FUSED TO MUTATED ESTROGEN RECEPTOR; WHEEL ACTIVITY;

ANIMALS; BEHAVIOR, ANIMAL; CUPRIZONE; DEMYELINATING DISEASES; FIBROBLAST GROWTH FACTOR 2; INTERPERSONAL RELATIONS; MICE; MICE, TRANSGENIC; NERVE FIBERS, MYELINATED; PSYCHOMOTOR PERFORMANCE; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 1; RECOVERY OF FUNCTION; SIGNAL TRANSDUCTION;

EID: 84880135775     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2013.05.010     Document Type: Article

References (21)

1. Armstrong R.C. Growth factor regulation of remyelination: behind the growing interest in endogenous cell repair of the CNS. Future Neurol. 2007, 2:689-697.
2. Armstrong R.C., Le T.Q., Flint N.C., Vana A.C., Zhou Y.X. Endogenous cell repair of chronic demyelination. J. Neuropathol. Exp. Neurol. 2006, 65:245-256.
3. Armstrong R.C., Le T.Q., Frost E.E., Borke R.C., Vana A.C. Absence of fibroblast growth factor 2 promotes oligodendroglial repopulation of demyelinated white matter. J. Neurosci. 2002, 22:8574-8585.
4. Chang A., Tourtellotte W.W., Rudick R., Trapp B.D. Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis. N. Engl. J. Med. 2002, 346:165-173.
5. Franklin R.J., ffrench-Constant C., Edgar J.M., Smith K.J. Neuroprotection and repair in multiple sclerosis. Nat. Rev. Neurol. 2012, 8:624-634.
6. Goldschmidt T., Antel J., Konig F.B., Bruck W., Kuhlmann T. Remyelination capacity of the MS brain decreases with disease chronicity. Neurology 2009, 72:1914-1921.
7. Hibbits N., Pannu R., John Wu T., Armstrong R.C. Cuprizone demyelination of the corpus callosum in mice correlates with altered social interaction and impaired bilateral sensorimotor coordination. ASN Neuro 2009, 1:153-164.
8. Koutsoudaki P.N., Skripuletz T., Gudi V., Moharregh-Khiabani D., Hildebrandt H., Trebst C., Stangel M. Demyelination of the hippocampus is prominent in the cuprizone model. Neurosci. Lett. 2009, 451:83-88.
9. Kuhlmann T., Miron V., Cui Q., Wegner C., Antel J., Bruck W. Differentiation block of oligodendroglial progenitor cells as a cause for remyelination failure in chronic multiple sclerosis. Brain 2008, 131:1749-1758.
10. Liebetanz D., Merkler D. Effects of commissural de- and remyelination on motor skill behaviour in the cuprizone mouse model of multiple sclerosis. Exp. Neurol. 2006, 202:217-224.
11. Manrique-Hoyos N., Jurgens T., Gronborg M., Kreutzfeldt M., Schedensack M., Kuhlmann T., Schrick C., Bruck W., Urlaub H., Simons M., Merkler D. Late motor decline after accomplished remyelination: impact for progressive multiple sclerosis. Ann. Neurol. 2012, 71:227-244.
12. Messersmith D.J., Murtie J.C., Le T.Q., Frost E.E., Armstrong R.C. Fibroblast growth factor 2 (FGF2) and FGF receptor expression in an experimental demyelinating disease with extensive remyelination. J. Neurosci. Res. 2000, 62:241-256.
13. Moy S.S., Nadler J.J., Perez A., Barbaro R.P., Johns J.M., Magnuson T.R., Piven J., Crawley J.N. Sociability and preference for social novelty in five inbred strains: an approach to assess autistic-like behavior in mice. Genes Brain Behav. 2004, 3:287-302.
14. Murtie J.C., Zhou Y.X., Le T.Q., Vana A.C., Armstrong R.C. PDGF and FGF2 pathways regulate distinct oligodendrocyte lineage responses in experimental demyelination with spontaneous remyelination. Neurobiol. Dis. 2005, 19:171-182.
15. Redwine J.M., Armstrong R.C. In vivo proliferation of oligodendrocyte progenitors expressing PDGFalphaR during early remyelination. J. Neurobiol. 1998, 37:413-428.
16. Schalomon P.M., Wahlsten D. Wheel running behavior is impaired by both surgical section and genetic absence of the mouse corpus callosum. Brain Res. Bull. 2002, 57:27-33.
17. Skripuletz T., Lindner M., Kotsiari A., Garde N., Fokuhl J., Linsmeier F., Trebst C., Stangel M. Cortical demyelination is prominent in the murine cuprizone model and is strain-dependent. Am. J. Pathol. 2008, 172:1053-1061.
18. Tobin J.E., Xie M., Le T.Q., Song S.K., Armstrong R.C. Reduced axonopathy and enhanced remyelination after chronic demyelination in fibroblast growth factor 2 (fgf2)-null mice: differential detection with diffusion tensor imaging. J. Neuropathol. Exp. Neurol. 2011, 70:157-165.
19. Xie M., Tobin J.E., Budde M.D., Chen C.I., Trinkaus K., Cross A.H., McDaniel D.P., Song S.K., Armstrong R.C. Rostrocaudal analysis of corpus callosum demyelination and axon damage across disease stages refines diffusion tensor imaging correlations with pathological features. J. Neuropathol. Exp. Neurol. 2010, 69:704-716.
20. Zhou Y.X., Flint N.C., Murtie J.C., Le T.Q., Armstrong R.C. Retroviral lineage analysis of fibroblast growth factor receptor signaling in FGF2 inhibition of oligodendrocyte progenitor differentiation. Glia 2006, 54:578-590.
21. Zhou Y.X., Pannu R., Le T.Q., Armstrong R.C. Fibroblast growth factor 1 (FGFR1) modulation regulates repair capacity of oligodendrocyte progenitor cells following chronic demyelination. Neurobiol. Dis. 2012, 45:196-205.